Skip to main content
. 2016 Sep 7;7(5):905–916. doi: 10.3945/an.116.012187

TABLE 1.

Studies published after April 2011 that included n–3 PUFA supplementation in animal models of AD1

Study, year (ref) AD model Supplement Duration Dose Outcome
Teng et al., 2015 (108) Transgenic APP/PS1 rats DHA from algal sources 4 mo 0.6% (wt:wt) of the diet Reduced Aβ plaque density
Improved behavioral testing
Hosono et al., 2015 (109) Tg2576 mice DHA 4 mo 2.4 g/kg diet Reduced Aβ(1–42)-to-Aβ(1–40) ratio
Torres et al., 2014 (110) Transgenic 5xFAD mice 2-Hydroxy DHA 4 mo 15 mg ⋅ kg–1 ⋅ d−1 Reduction in Aβ accumulation
Improved cognitive scores
Ma et al., 2014 (111) Tau knockout mice DHA alone or with α-lipoic acid 5 mo 0.6% DHA (or with 500 ppm α-lipoate) Protected against hyperphosphorylation
Lower hippocampal synaptic deficits
Improved Morris water maze deficits
Fiol-deRoque et al., 2013 (112) Transgenic 5xFAD mice 2-Hydroxy DHA 4 mo 15 mg ⋅ kg–1 ⋅ d−1 Improved radial arm maze test scores
Labrousse et al., 2012 (113) Aged C57Bl6/J mice EPA+DHA 2 mo 5.45 g EPA + 3.6 g DHA/kg diet Reduced inflammatory markers
Improved spatial memory deficits
Kariv-Inbal et al., 2012 (114) ApoE-targeted replacement mice Fish oil 4 mo 3.03 g fish oil/kg diet Reduced hippocampal Aβ concentrations
Improved behavioral performance
Hashimoto et al., 2011 (115) Aβ-infused rats Purified EPA+DHA 12 wk 300 mg ⋅ kg–1 ⋅ d−1 Improved reference and working memory
1

Aβ, amyloid β APP, amyloid precursor protein; ppm, parts per million; PS1, presenilin 1; ref, reference.